Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

HCW Biologics (HCWB) Debt Ratio (2022 - 2025)

HCW Biologics (HCWB) has disclosed Debt Ratio for 4 consecutive years, with 0.27 as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Debt Ratio rose 12.05% year-over-year to 0.27, compared with a TTM value of 0.27 through Sep 2025, up 12.05%, and an annual FY2024 reading of 0.21, changed N/A over the prior year.
  • Debt Ratio was 0.27 for Q3 2025 at HCW Biologics, up from 0.22 in the prior quarter.
  • Across five years, Debt Ratio topped out at 0.82 in Q4 2022 and bottomed at 0.0 in Q1 2023.
  • Average Debt Ratio over 4 years is 0.18, with a median of 0.21 recorded in 2024.
  • The sharpest move saw Debt Ratio skyrocketed 7126.04% in 2024, then grew 12.05% in 2025.
  • Year by year, Debt Ratio stood at 0.82 in 2022, then tumbled by 99.6% to 0.0 in 2023, then skyrocketed by 6220.71% to 0.21 in 2024, then grew by 28.1% to 0.27 in 2025.
  • Business Quant data shows Debt Ratio for HCWB at 0.27 in Q3 2025, 0.22 in Q2 2025, and 0.24 in Q1 2025.